Literature DB >> 20690605

The N-glycome of human plasma.

Katherine A Stumpo1, Vernon N Reinhold.   

Abstract

N-linked glycans isolated from human plasma proteins have been profiled and sequenced by mass spectrometry using an ion trap instrument (ITMSn). The released glycans were prepared as reduced, methylated analogues and directly infused into a chip-based nanoelectrospray ionization system and analyzed by ITMSn. The resulting mass profiles (MS1) of IgG-depleted and nondepleted plasma samples were contrasted and these results were again compared with recent literature reports. Before depletion, approximately 50 independent glycan ions were detected; this more than doubled to 106 after depletion. The mass range profiled was 1-5 kDa which included many doubly and triply charged ions that were resolved by higher MS resolution. Selected ions in the depleted sample were disassembled to define their detailed structure providing a high-performance sequencing result. The simplicity of this nonchromatographic, direct infusion and gas-phase structural characterization compares most favorably with the latest reports using alternative instrumentation and adjunct techniques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20690605      PMCID: PMC2933516          DOI: 10.1021/pr100528k

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  34 in total

1.  Mechanistic investigation of ionization suppression in electrospray ionization.

Authors:  R King; R Bonfiglio; C Fernandez-Metzler; C Miller-Stein; T Olah
Journal:  J Am Soc Mass Spectrom       Date:  2000-11       Impact factor: 3.109

Review 2.  Practical implications of some recent studies in electrospray ionization fundamentals.

Authors:  N B Cech; C G Enke
Journal:  Mass Spectrom Rev       Date:  2001 Nov-Dec       Impact factor: 10.946

3.  Rapid de-O-glycosylation concomitant with peptide labeling using microwave radiation and an alkyl amine base.

Authors:  Stephanie Maniatis; Hui Zhou; Vernon Reinhold
Journal:  Anal Chem       Date:  2010-03-15       Impact factor: 6.986

Review 4.  Carbohydrate molecular weight profiling, sequence, linkage, and branching data: ES-MS and CID.

Authors:  V N Reinhold; B B Reinhold; C E Costello
Journal:  Anal Chem       Date:  1995-06-01       Impact factor: 6.986

Review 5.  Glycoprotein glycosylation and cancer progression.

Authors:  J W Dennis; M Granovsky; C E Warren
Journal:  Biochim Biophys Acta       Date:  1999-12-06

Review 6.  Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

Review 7.  Chemical glycobiology.

Authors:  C R Bertozzi; L L Kiessling
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

Review 8.  The joys of HexNAc. The synthesis and function of N- and O-glycan branches.

Authors:  H Schachter
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

9.  Elimination of oxidative degradation during the per-O-methylation of carbohydrates.

Authors:  Ionel Ciucanu; Catherine E Costello
Journal:  J Am Chem Soc       Date:  2003-12-31       Impact factor: 15.419

10.  Stability of N-glycan profiles in human plasma.

Authors:  Olga Gornik; Jasenka Wagner; Maja Pucić; Ana Knezević; Irma Redzic; Gordan Lauc
Journal:  Glycobiology       Date:  2009-09-02       Impact factor: 4.313

View more
  34 in total

Review 1.  Toward a platform for comprehensive glycan sequencing.

Authors:  Vernon Reinhold; Hailong Zhang; Andrew Hanneman; David Ashline
Journal:  Mol Cell Proteomics       Date:  2013-02-25       Impact factor: 5.911

2.  Populations of metal-glycan structures influence MS fragmentation patterns.

Authors:  Feifei Zhu; Matthew S Glover; Huilin Shi; Jonathan C Trinidad; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2014-10-15       Impact factor: 3.109

3.  Improving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure.

Authors:  Ioan Marginean; Scott R Kronewitter; Ronald J Moore; Gordon W Slysz; Matthew E Monroe; Gordon Anderson; Keqi Tang; Richard D Smith
Journal:  Anal Chem       Date:  2012-10-17       Impact factor: 6.986

4.  Integrating mass spectrometry-based plasma (or serum) protein N-glycan profiling into the clinical practice?

Authors:  Arnaud Bruneel; François Fenaille
Journal:  Ann Transl Med       Date:  2019-09

5.  GPQuest: A Spectral Library Matching Algorithm for Site-Specific Assignment of Tandem Mass Spectra to Intact N-glycopeptides.

Authors:  Shadi Toghi Eshghi; Punit Shah; Weiming Yang; Xingde Li; Hui Zhang
Journal:  Anal Chem       Date:  2015-05-06       Impact factor: 6.986

6.  Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.

Authors:  Petra Darebna; Petr Novak; Radek Kucera; Ondrej Topolcan; Miloslav Sanda; Radoslav Goldman; Petr Pompach
Journal:  J Proteomics       Date:  2016-09-16       Impact factor: 4.044

7.  An in-depth Comparison of the Pediatric and Adult Urinary N-glycomes.

Authors:  Haiying Li; Viral Patel; Shannon E DiMartino; John W Froehlich; Richard S Lee
Journal:  Mol Cell Proteomics       Date:  2020-07-31       Impact factor: 5.911

8.  LC-MS/MS of permethylated N-glycans derived from model and human blood serum glycoproteins.

Authors:  Yunli Hu; Tarek Shihab; Shiyue Zhou; Kerry Wooding; Yehia Mechref
Journal:  Electrophoresis       Date:  2016-04-05       Impact factor: 3.535

9.  Glycomic analysis using glycoprotein immobilization for glycan extraction.

Authors:  Shuang Yang; Yan Li; Punit Shah; Hui Zhang
Journal:  Anal Chem       Date:  2013-05-20       Impact factor: 6.986

10.  Structural feature ions for distinguishing N- and O-linked glycan isomers by LC-ESI-IT MS/MS.

Authors:  Arun V Everest-Dass; Jodie L Abrahams; Daniel Kolarich; Nicolle H Packer; Matthew P Campbell
Journal:  J Am Soc Mass Spectrom       Date:  2013-04-20       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.